Subconjunctival Aflibercept Inhibits Corneal Angiogenesis and VEGFR-3⁺CD11b⁺ Cells

Scientists investigated the effects of subconjunctival injection of aflibercept, a soluble protein decoy for VEGFR-1 and VEGFR-2, on corneal angiogenesis and VEGFR-expressing CD11b+ cells in a mouse model of suture-induced corneal neovascularization.